Progression of symptoms in the early and middle stages of Huntington disease.

No abstract is available for this paper.

• Publication year

  2001

• Venue

  Archives of Neurology

• Publication date

  2001-02-01

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1001/ARCHNEUR.58.2.273PMID 11176966
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Confirmation of subtle motor changes among presymptomatic carriers of the Huntington disease gene.

  2000cited by this paper
• Motor disorder in Huntington's disease begins as a dysfunction in error feedback control

  2000cited by this paper
• Longitudinal cognitive and motor changes among presymptomatic Huntington disease gene carriers.

  1999cited by this paper
• Genetic instabilities and hereditary neurological diseases

  1998cited by this paper
• Early cognitive and motor symptoms in identified carriers of the gene for Huntington disease.

  1997cited by this paper
• Unified Huntington's disease rating scale: Reliability and consistency

  1996cited by this paper
• Executive and mnemonic functions in early Huntington's disease.

  1996cited by this paper
• Unified Huntington's disease rating scale: reliability and consistency

  1996cited by this paper
• Motor changes in presymptomatic Huntington disease gene carriers.

  1996cited by this paper
• Characteristics of individuals with Huntington disease in long‐term care

  1996cited by this paper
• Cognitive scores in carriers of huntington's disease gene compared to noncarriers

  1995cited by this paper
• Cognitive performance in UK sample of presymptomatic people carrying the gene for Huntington's disease.

  1995cited by this paper
• Longitudinal neuropsychological and genetic linkage analysis of persons at risk for Huntington's disease.

  1995cited by this paper
• A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. The Huntington's Disease Collaborative Research Group.

  1993cited by this paper
• Relationship between trinucleotide repeat expansion and phenotypic variation in Huntington's disease

  1993cited by this paper
• Cognitive and Motor Correlates of Everyday Functioning in Early Huntington's Disease

  1993cited by this paper
• Huntington's Disease

  1990influential reference
• Huntington's disease in venezuela: 7 years of follow‐up on symptomatic and asymptomatic individuals

  1990cited by this paper
• Are there neuropsychologic manifestations of the gene for Huntington's disease in asymptomatic, at-risk individuals?

  1990cited by this paper
• Oculomotor defects in patients with Huntington's disease and their offspring.

  1988cited by this paper
• Presymptomatic neuropsychological impairment in Huntington's disease.

  1988cited by this paper
• Huntington's disease in Venezuela

  1986cited by this paper
• Huntington's disease. Pathogenesis and management.

  1986cited by this paper
• The measurement of abnormal movement: methods developed for Huntington's disease.

  1983cited by this paper
• Huntington’s Chorea

  1981cited by this paper
• Regression Models for Ordinal Data

  1980cited by this paper
• Huntington disease

  1979cited by this paper
• On Probabilities of Rectangles in Multivariate Student Distributions: Their Dependence on Correlations

  1971cited by this paper

• What is the prevalence of sleep disturbances among people with Huntington disease and pre-manifest genetic expansion carriers? A systematic review and meta-analysis.

  2026cites this paper
• Surface-Engineered Precision Nano-Systems for Targeted Treatment of Huntington's Disease: A Review of Recent Advancements.

  2026cites this paper
• Musical Distractions: Music-Based Rhythmic Auditory Stimulation Fails to Improve Gait in Huntington’s Disease

  2025cites this paper
• The physiological and pathological effects of sphingolipid metabolism and signaling in the central nervous system

  2025cites this paper
• Upper Extremity Motor Performance During a Shirt Buttoning Task in Huntington's Disease.

  2025cites this paper
• A digital motor score for sensitive detection of progression in Huntington’s disease

  2025cites this paper
• Medication Use and Treatment Indications in Huntington's Disease; Analyses from a Large Cohort

  2024cites this paper
• Glucocorticoid receptor antagonist CORT113176 attenuates motor and neuropathological symptoms of Huntington's disease in R6/2 mice.

  2024cites this paper
• Symptom-led staging for primary progressive aphasia

  2023cites this paper
• Graphomotor Dysfluency as a Predictor of Disease Progression in Premanifest Huntington’s Disease

  2023cites this paper
• Update of Rehabilitation in Huntington’s Disease: Narrative Review

  2023cites this paper
• Clustering and prediction of disease progression trajectories in Huntington's disease: An analysis of Enroll-HD data using a machine learning approach

  2023cites this paper
• “Man, This Isn’t Easy”: Exploring the Manifestation of Parentification Among Young Carers of a Parent with Huntington’s Disease

  2023cites this paper
• Perturbed actin cap as a new personalized biomarker in primary fibroblasts of Huntington’s disease patients

  2023cites this paper
• Symptom‐led staging for semantic and non‐fluent/agrammatic variants of primary progressive aphasia

  2023cites this paper
• Neurophysiology of cerebellar ataxias and gait disorders

  2023cites this paper
• Dietary fibre confers therapeutic effects in a preclinical model of Huntington's disease.

  2023cites this paper
• Sexual Dimorphism in Neurodegenerative Diseases and in Brain Ischemia

  2022cites this paper
• Second Sphere Interactions in Amyloidogenic Diseases.

  2022cites this paper
• The Lived Experiences of Depression in Huntington’s Disease: A Qualitative Study

  2022cites this paper
• Lower urinary tract dysfunction in uncommon neurological diseases: A report of the neurourology promotion committee of the International Continence Society

  2022cites this paper
• A rationale for considering heart/brain axis control in neuropsychiatric disease

  2022cites this paper
• Perturbed actin cap and nuclear morphology in primary fibroblasts of Huntington’s disease patients as a new phenotypic marker for personalized drug evaluation

  2022cites this paper
• Current and Possible Future Therapeutic Options for Huntington’s Disease

  2022cites this paper
• Phospholipid Profiles Are Selectively Altered in the Putamen and White Frontal Cortex of Huntington’s Disease

  2022cites this paper
• Microarray profiling of hypothalamic gene expression changes in Huntington’s disease mouse models

  2022cites this paper
• Prolonged psychosis before onset of neurological symptoms; an atypical clinical manifestation of Huntington’s disease

  2022cites this paper
• Modeling neurodegenerative disorders in zebrafish.

  2022cites this paper
• Computational insights into missense mutations in HTT gene causing Huntington’s disease and its interactome networks

  2022cites this paper
• Pathogenesis of Huntington’s Disease: An Emphasis on Molecular Pathways and Prevention by Natural Remedies

  2022cites this paper
• Understanding the Burdens Associated with Huntington’s Disease in Manifest Patients and Care Partners–Comparing to Parkinson’s Disease and the General Population

  2022cites this paper
• Quantification of Huntington’s Disease Related Markers in the R6/2 Mouse Model

  2021cites this paper
• Palliative Care in Movement Disorders: an Evolving Field

  2021cites this paper
• Repetitive transcranial magnetic stimulation for major depressive disorder comorbid with huntington’s disease: a case report

  2021cites this paper
• The long and the short of Huntington’s disease: how the sphingolipid profile is shifted in the caudate of advanced clinical cases

  2021cites this paper
• Mitochondrial Abnormalities and Synaptic Damage in Huntington’s Disease: a Focus on Defective Mitophagy and Mitochondria-Targeted Therapeutics

  2021cites this paper
• Mild cognitive impairment and dementia in motor manifest Huntington's disease: Classification and prevalence.

  2020cites this paper
• Fundamentally altered global- and microstate EEG characteristics in Huntington's disease.

  2020cites this paper
• Neurological Disorders in the Lower Extremity

  2020cites this paper
• Alzheimer’s Dementia

  2020cites this paper
• Fundamentally altered global- and microstate EEG characteristics in Huntingtonâ€TMs disease

  2020cites this paper
• Huntington’s Disease- An Updated Review

  2020cites this paper
• Huntington’s Disease

  2020cites this paper
• Index

  2020cites this paper
• VMAT2 inhibitors for the treatment of hyperkinetic movement disorders.

  2020cites this paper
• Vascular Dementia

  2020cites this paper
• Gait variability as digital biomarker of disease severity in Huntington’s disease

  2020cites this paper
• Preface

  2020cites this paper
• Glossary

  2020cites this paper
• Parkinson’s Disease Dementia

  2020cites this paper
• Answers to Exercises

  2020cites this paper
• Sexual dysfunction in Huntington's Disease - a systematic review.

  2020influential citation
• Test Protocol

  2020cites this paper
• Age of onset and behavioral manifestations in Huntington's disease: An Enroll‐HD cohort analysis

  2020cites this paper
• Neuronal chloride transporters in neurodegenerative diseases

  2020cites this paper
• Language in Dementia

  2020cites this paper
• Bibliography

  2020cites this paper
• Nosology and Phenomenology of Psychosis in Movement Disorders

  2020cites this paper
• Test Material

  2020cites this paper
• Psychosis and longitudinal outcomes in Huntington disease: the COHORT Study

  2019cites this paper
• The Urologic Management of Huntington Chorea

  2019cites this paper
• Structure of Membrane-Bound Huntingtin Exon 1 Reveals Membrane Interaction and Aggregation Mechanisms.

  2019cites this paper
• Stress and Glucocorticoids as Experience-Dependent Modulators of Huntington's Disease

  2019cites this paper
• Augmentative and Alternative Communication Use by Individuals With Huntington's Disease: Benefits and Challenges of Implementation

  2019cites this paper
• Normalizing glucocorticoid levels attenuates metabolic and neuropathological symptoms in the R6/2 mouse model of huntington's disease.

  2019cites this paper
• Role of Phosphorylated Tau and Glucose Synthase Kinase 3 Beta in Huntington’s Disease Progression

  2019cites this paper
• Planning for an uncertain future in progressive neurological disease: a qualitative study of patient and family decision-making with a focus on eating and drinking

  2018cites this paper
• Protein misassembly and aggregation as potential convergence points for non-genetic causes of chronic mental illness

  2018cites this paper
• Understandings of psychological difficulties in people with the Huntington’s disease gene mutation and their expectations of psychological therapy

  2018cites this paper
• Antidepressant Effects of Probucol on Early-Symptomatic YAC128 Transgenic Mice for Huntington's Disease

  2018cites this paper
• Addressing and Managing Requests to Hasten Death

  2018cites this paper
• Regional subcortical shape analysis in premanifest Huntington's disease

  2018cites this paper
• The Clinical Picture of Psychosis in Manifest Huntington's Disease: A Comprehensive Analysis of the Enroll-HD Database

  2018cites this paper
• Anorectal Dysfunction in Presymptomatic Mutation Carriers and Patients with Huntington’s Disease

  2018cites this paper
• Understandings of psychological difficulties in people with the Huntington's disease gene and their expectations of psychological therapy

  2018cites this paper
• Vergence and Strabismus in Neurodegenerative Disorders

  2018cites this paper
• Understanding patient-reported outcome measures in Huntington disease: at what point is cognitive impairment related to poor measurement reliability?

  2018cites this paper
• Worsening Choreoathetosis in Huntington's Disease with Fluoxetine, Lisdexamfetamine, and Melatonin: A Case Report.

  2018cites this paper
• “This Condition isn't Going to get any Better so I can't see why we're Prolonging it”: Risks and Benefits of using Empirical Research to Inform Normative Decisions Concerning End-of-Life Care

  2018cites this paper
• 4 Biomarkers for Huntington ’ s Disease

  2018cites this paper
• Pharmacological intervention of early neuropathy in neurodegenerative diseases.

  2017cites this paper
• Assessing Decline: Visualising Progression in Huntington’s Disease using a Clinical Dashboard with Enroll-HD Data

  2017cites this paper
• Palliative Care in Huntington Disease: Personal Reflections and a Review of the Literature

  2017cites this paper
• Disability milestones in Huntington disease

  2017cites this paper
• Formation of hippocampal mHTT aggregates leads to impaired spatial memory, neuronal plasticity and adult neurogenesis

  2017cites this paper
• Risk factors for the onset and progression of Huntington disease

  2017cites this paper
• Patient‐reported outcomes in Huntington's disease: Quality of life in neurological disorders (Neuro‐QoL) and Huntington's disease health‐related quality of life (HDQLIFE) physical function measures

  2017cites this paper
• Huntington's Disease

  2017cites this paper
• Oxytocin effects on emotional response to others' faces via serotonin system in autism: A pilot study.

  2017cites this paper
• An Automated Home-Cage System to Assess Learning and Performance of a Skilled Motor Task in a Mouse Model of Huntington’s Disease

  2017influential citation
• Interrogation of Rab8 as a therapeutic target for Huntington’s disease in Drosophila melanogaster

  2017cites this paper
• The role of serotonergic dysfunction in the etiology of affective disorder in a Huntington’s disease translational mouse model

  2017cites this paper
• Exploring the impact of a diagnosis of Huntington’s Disease on couple relationships

  2017cites this paper
• Neuropsychiatric Burden in Huntington’s Disease

  2017influential citation
• A Case of Two Repeats: Huntington's Disease and Spinocerebellar Ataxia Type 8

  2017cites this paper
• Metal Biology Associated with Huntington’s Disease

  2017cites this paper
• Alterations of Synaptic Function in Huntington's Disease

  2017cites this paper
• The Endocannabinoid System in Local and Systemic Inflammation

  2017cites this paper
• Thesis: Snoezelen® as Multisensory Stimulation to Promote Healthy Ageing

  2017cites this paper
• Female Sexual Dysfunction in Presymptomatic Mutation Carriers and Patients with Huntington’s Disease

  2017cites this paper